SCHEMBL3461371

SCHEMBL3461371

OC(=S)SCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
CA9 Q16790 1/20 0.65
IDO1 P14902 7/20 0.58
NOS1 P29475 2/20 0.58
NOS3 P29474 1/20 0.58
NOS2 P35228 1/20 0.58
TDP1 Q9NUW8 2/20 0.46
GAA P10253 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11844622 0.98 CA12 (0.63) CA12CA1CA2CA9IDO1
SCHEMBL10821320 0.98 CA12 (0.63) CA12CA1CA2CA9IDO1
Piperazine SCHEMBL28323094 0.88 CA12 (0.53) CA12CA1CA2CA9IDO1
SCHEMBL161188 0.85 CA12 (0.65) CA12CA1CA2CA9IDO1
Carbazole SCHEMBL28214859 0.83 CA12 (0.49) CA12CA1CA2CA9IDO1
SCHEMBL162537 0.83 CA12 (0.63) CA12CA1CA2CA9IDO1
SCHEMBL3461369 0.81 CA12 (0.61) CA12CA1CA2CA9IDO1
SCHEMBL1319633 0.81 IDO1 (0.65) CA12CA1CA2CA9IDO1
SCHEMBL224486 0.81 CA12 (0.61) CA12CA1CA2CA9IDO1
SCHEMBL22772246 0.81 CA12 (0.61) CA12CA1CA2CA9IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105776516-B A kind of biological contact oxidation process removes the device and its working method of carbon tetrachloride in underground water 徐州市城区水资源管理处 2018-07-20 CN claimed
CN-105776516-A Device for removing carbon tetrachloride in underground water by biological contact oxidation process and working method thereof 徐州市城区水资源管理处 2016-07-20 CN claimed
CN-110167982-A The manufacturing method of block copolymer and block copolymer 电化株式会社 2019-08-23 CN disclosed
CN-110128605-A Poly- (methyl) acrylate star polymer for lubricant additive application 雅富顿化学公司 2019-08-16 CN disclosed
CN-105776516-B A kind of biological contact oxidation process removes the device and its working method of carbon tetrachloride in underground water 徐州市城区水资源管理处 2018-07-20 CN disclosed
CN-108137722-A RAFT polymer without thio-carbonyl sulfide and preparation method thereof 汉高知识产权控股有限责任公司 2018-06-08 CN disclosed
CN-104704014-B Loose core star polymers and lubricating compositions thereof 路博润公司 2017-11-03 CN disclosed
CN-104125984-B9 Fluoroacrylate block copolymers with low dynamic surface tension 巴斯夫欧洲公司 2017-09-22 CN disclosed
CN-104125984-B Fluoroacrylate block copolymers with low dynamic surface tension 巴斯夫欧洲公司 2017-06-20 CN disclosed
CN-105849211-A Acrylic dispersants with fused aromatic imide anchor groups 路博润先进材料公司 2016-08-10 CN disclosed
CN-105776516-A Device for removing carbon tetrachloride in underground water by biological contact oxidation process and working method thereof 徐州市城区水资源管理处 2016-07-20 CN disclosed
EP-2226632-B1 METHOD FOR SCREENING OF CELL-PROTECTING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-02-12 EP disclosed
US-8450070-B2 Method for screening of cell-protecting agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-05-28 US disclosed
US-20100279311-A1 METHOD FOR SCREENING OF CELL-PROTECTING AGENT TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-04 US disclosed
EP-2226632-A1 METHOD FOR SCREENING OF CELL-PROTECTING AGENT Takeda Pharmaceutical Company Limited (JP) 2010-09-08 EP disclosed
US-4740623-A BENZYL CHLORIDE REACTED WITH SODIUM HYDROSULFIDE STAUFFER CHEMICAL COMPANY (US) 1988-04-26 US disclosed
US-4215043-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-07-29 US disclosed
US-4203897-A Penam derivatives FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) 1980-05-20 US disclosed
US-4084049-A CEPHALOSPORIN ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1978-04-11 US disclosed
US-3954732-A BACTERICIDAL PENICILLINS FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279311-A1 METHOD FOR SCREENING OF CELL-PROTECTING AGENT HSF1, HSP90AB1, HSP90AA1 CA12 3518/4885CA1 2491/4885CA2 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.